Premier Path Wealth Partners
TMO icon

Premier Path Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History

Premier Path Wealth Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.28M Sell
3,381
-564
-14% -$335K 0.27% 90
2026
Q2 		$1.98M Sell
3,945
-437
-10% -$210K 0.23% 99
2026
Q1 		$2.15M Buy
4,382
+73
+2% +$39.6K 0.28% 82
2025
Q4 		$2.5M Sell
4,309
-245
-5% -$139K 0.32% 71
2025
Q3 		$2.21M Buy
4,554
+2,908
+177% +$1.35M 0.28% 78
2025
Q2 		$667K Sell
1,646
-247
-13% -$103K 0.09% 218
2025
Q1 		$942K Buy
1,893
+104
+6% +$56.3K 0.15% 168
2024
Q4 		$931K Sell
1,789
-84
-4% -$46.2K 0.14% 164
2024
Q3 		$1.16M Sell
1,873
-13
-0.7% -$7.7K 0.18% 143
2024
Q2 		$1.04M Buy
1,886
+13
+0.7% +$7.45K 0.18% 142
2024
Q1 		$1.09M Sell
1,873
-56
-3% -$31.4K 0.2% 129
2023
Q4 		$1.02M Buy
+1,929
New +$934K 0.23% 115

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $19.7B AUM 7.08% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Premier Path Wealth Partners's TMO Position: Q3 2026 in Review

Premier Path Wealth Partners reduced its Thermo Fisher Scientific (TMO) stake by 14% in Q3 2026, selling an estimated $335K and leaving 3,381 shares worth $2.28M. The position accounts for 0.27% of the portfolio, ranked #90.

Premier Path Wealth Partners first reported a position in TMO in Q4 2023 and has held it in 12 quarters since. The position peaked at $2.5M in Q4 2025. 1,358 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Premier Path Wealth Partners held 3,381 shares of Thermo Fisher Scientific worth $2.28M as of Q3 2026.
  • Premier Path Wealth Partners sold 564 Thermo Fisher Scientific shares in Q3 2026, an estimated $335K.
  • Thermo Fisher Scientific made up 0.27% of Premier Path Wealth Partners's portfolio in Q3 2026, its #90 holding.
  • Premier Path Wealth Partners first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 12 quarters since.
  • Premier Path Wealth Partners's Thermo Fisher Scientific position peaked at $2.5M in Q4 2025.
  • 1,358 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Premier Path Wealth Partners's 13F filing for Q3 2026, filed 16 Oct 2026.